Aslan Pharmaceuticals Stock Forecast - Polynomial Regression

ASLNDelisted Stock  USD 0.60  0.03  4.76%   
The Polynomial Regression forecasted value of Aslan Pharmaceuticals on the next trading day is expected to be 0.63 with a mean absolute deviation of 0.22 and the sum of the absolute errors of 13.50. Aslan Stock Forecast is based on your current time horizon.
  
Aslan Pharmaceuticals polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for Aslan Pharmaceuticals as well as the accuracy indicators are determined from the period prices.

Aslan Pharmaceuticals Polynomial Regression Price Forecast For the 1st of December

Given 90 days horizon, the Polynomial Regression forecasted value of Aslan Pharmaceuticals on the next trading day is expected to be 0.63 with a mean absolute deviation of 0.22, mean absolute percentage error of 0.08, and the sum of the absolute errors of 13.50.
Please note that although there have been many attempts to predict Aslan Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Aslan Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Aslan Pharmaceuticals Stock Forecast Pattern

Backtest Aslan PharmaceuticalsAslan Pharmaceuticals Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Aslan Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Aslan Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria115.6195
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2213
MAPEMean absolute percentage error0.0978
SAESum of the absolute errors13.5012
A single variable polynomial regression model attempts to put a curve through the Aslan Pharmaceuticals historical price points. Mathematically, assuming the independent variable is X and the dependent variable is Y, this line can be indicated as: Y = a0 + a1*X + a2*X2 + a3*X3 + ... + am*Xm

Predictive Modules for Aslan Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aslan Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.600.600.60
Details
Intrinsic
Valuation
LowRealHigh
0.570.570.66
Details

View Aslan Pharmaceuticals Related Equities

 Risk & Return  Correlation

Aslan Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Aslan Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aslan Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Aslan Pharmaceuticals stock market strength indicators, traders can identify Aslan Pharmaceuticals entry and exit signals to maximize returns.

Aslan Pharmaceuticals Risk Indicators

The analysis of Aslan Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aslan Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aslan stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Aslan Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aslan Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aslan Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aslan Stock

  0.75BKRKY Bank RakyatPairCorr
  0.69BKRKF PT Bank RakyatPairCorr
  0.75PPERY Bank Mandiri PerseroPairCorr
  0.69PPERF Bank Mandiri PerseroPairCorr

Moving against Aslan Stock

  0.86DIS Walt Disney Sell-off TrendPairCorr
  0.85BAC Bank of America Aggressive PushPairCorr
  0.81AXP American Express Fiscal Year End 24th of January 2025 PairCorr
  0.79CVX Chevron Corp Sell-off TrendPairCorr
  0.76CSCO Cisco Systems Sell-off TrendPairCorr
The ability to find closely correlated positions to Aslan Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aslan Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aslan Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aslan Pharmaceuticals to buy it.
The correlation of Aslan Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aslan Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aslan Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aslan Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in Aslan Stock

If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets